Placebo suspension
Sponsors
University of Ulm, Yale University, GlaxoSmithKline, Pfizer, Johannes Gutenberg University Mainz
Conditions
ADHDAcute Myocardial InfarctionCoronary Artery DiseaseDiabetes Mellitus, Type 1Drug Sensitive TuberculosisDrug-resistant TuberculosisFunctional Abdominal PainFunctional Dyspepsia
Phase 1
Study to Assess Cardiac Conduction of GSK1349572
CompletedNCT00996021
Start: 2009-09-30End: 2009-12-31Updated: 2010-01-25
Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin
CompletedNCT01127906
Start: 2010-06-30End: 2010-09-30Updated: 2010-09-23
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
CompletedNCT02755064
Start: 2010-06-30End: 2013-11-30Updated: 2016-04-28
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults
CompletedNCT03758612
Start: 2019-01-16End: 2020-03-15Updated: 2024-12-09
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
CompletedNCT04493671
Start: 2020-06-08End: 2022-11-15Updated: 2025-06-04
First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
Active, not recruitingNCT05781399
Start: 2022-10-31End: 2025-12-15Target: 135Updated: 2025-07-31
A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
WithdrawnNCT06260267
Start: 2024-03-12End: 2026-01-15Updated: 2024-10-18
Phase 2
Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)
CompletedNCT00669227
Start: 2005-10-31Updated: 2014-06-10
A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients
CompletedNCT02119260
Start: 2014-06-09End: 2016-12-25Updated: 2018-09-27
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingNCT05714085
Start: 2023-05-31End: 2032-04-15Target: 342Updated: 2026-03-31
Phase 3
Unknown Phase
A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis
CompletedNCT00727740
Start: 2005-08-31End: 2012-08-31Updated: 2017-01-18
Efficacy of Open Label Placebo in Children With FGIDs
CompletedNCT02389998
Start: 2014-07-31End: 2019-07-31Updated: 2021-07-23